purine/pyrimidine metabolism Flashcards
Drugs affecting pyrimidine synthesis
Leflunomide MTX, TMP, pyrimethanine 5-FU/capecitabine (prodrug)
Drugs affecting purine synthesis
6-MP, azathioprine (prodrug) mycophenolate and ribavirin
Drug that affects both pyrimidine/purine synthesis
Hydroxyurea inhibits ribonucleotide reductase (UDP to dUDP) build up of UDP
inhibits dihydroorotate dehydrogenase
leflunomide no orotic acid (carbamoyl phosphate + aspartate) inhibit pyrimidine
inhibits dihydrofolate reductase decrease deoxythymidine monophosphate (dTMP) in humans, bacteria, protozoa
MTX, TMP, pyrimethamine (inhibit pyrimidine) get build up of DHF
- MTX=eukaryotes
- TMP=prokaryotes
- pyrimethamine=protozoa
- form 5-FdUMP
- inhibits thymidylate synthase decrease dTMP increase dUMP
5-FU and its prodrug capecitabine inhibit pyrimidine
inhibit de novo purine synthesis
6-MP and azathioprine (prodrug) no IMP made build up of PRPP
inhibit inosine monophosphate dehydrogenase
mycophenolate ribavirin build up of IMP can’t make GMP (inhibit purine)
pyrimidine base production requires
aspartate
de novo purine synthesis requires
aspartate glycine glutamine THF
Start of pyrimidine synthesis
glutamine + CO2 + 2 ATP Carbamoyl phosphate synthetase II (CPS2) in cyTWOsol
Start of purine synthesis
Ribose-5-P –> PRPP –> IMP
In orotic acuduria, cannot make
UMP from orotic acid and PRPP
one of major causes of AR SCID
adenosine deaminase deficiency
adenosine deaminase is required for
degradation of adenosine and deoxyadenosine decrease ADA cannot make inosine from adenosine increase dATP increase lymphotoxicity = AR SCID
Disease with defective purine salvage d/t to absent HGPRT
Lesch-Nyhan syndrome XR
HGPRT converts
hypoxanthine to IMP guanine to GMP
what consequences come from absent HGPRT (Lesch-Nyhan syndrome, XR)
excess uric acid production and de novo purine synthesis